Please use this identifier to cite or link to this item:
https://hdl.handle.net/10137/7333
Title: | Long term survival rates of patients undergoing vitrectomy for diabetic retinopathy in an Australian population: a population based audit. |
Authors: | Liu, Ebony Estevez, Jose Kaidonis, Georgia Hassall, Mark Phillips, Russell Raymond, Grant Saha, Niladri Wong, George H C Gilhotra, Jagjit Burdon, Kathryn Landers, John Henderson, Tim Newland, Henry Lake, Stewart Craig, Jamie E |
Citation: | Clinical & experimental ophthalmology 2019-01-20 |
Abstract: | Five year survival rates in patients undergoing vitrectomy for diabetic retinopathy (DR) vary from 68-95%. No study has been conducted in an Australian population. We aimed to determine the survival rates of patients undergoing diabetic vitrectomy in an Australian population. Retrospective audit, tertiary centre hospitals and private practices PARTICIPANTS: All individuals in South Australia and the Northern Territory who underwent their first vitrectomy for diabetic complications between 1st January 2007 to 31st December 2011 METHODS: An audit of all eligible participants has been completed previously. Survival status as of 6th July 2018 and cause of death were obtained using SA/NT DataLink. Kaplan-Meier survival curves and multivariate cox-regressions were used to analyse survival rates and identify risk factors for mortality. 5, 7 and 9 year survival rates RESULTS: The 5, 7 and 9 year survival rates were 84.4%, 77.9% and 74.7% respectively. The most common cause of death was cardiovascular disease. Associated with increased mortality independent of age were Indigenous ethnicity (HR 2.04, 95% CI 1.17-3.57, p=0.012), chronic renal failure (HR 1.76, 95% CI=1.07-2.89, p=0.026) and renal failure requiring dialysis (HR 2.32, 95% CI 1.25-4.32, p=0.008). Long-term survival rates after diabetic vitrectomy in Australia are similar to rates reported in other populations. Indigenous ethnicity and chronic renal failure were the most significant factors associated with long term mortality. This information can guide allocation of future resources to improve the prognosis of these high risk groups. |
Click to open PubMed article: | https://www.ezpdhcs.nt.gov.au/login?url=https://www.ncbi.nlm.nih.gov/pubmed//30663192 |
Click to open Pubmed Article: | https://www.ezpdhcs.nt.gov.au/login?url=https://www.ncbi.nlm.nih.gov/pubmed//30663192 |
Journal title: | Clinical & experimental ophthalmology |
Publication Date: | 2019-01-20 |
Type: | Journal Article |
URI: | https://hdl.handle.net/10137/7333 |
DOI: | 10.1111/ceo.13466 |
Orcid: | https://orcid.org/0000-0002-4542-9084 https://orcid.org/0000-0003-2722-0700 https://orcid.org/0000-0002-7558-0607 https://orcid.org/0000-0002-6180-7954 https://orcid.org/0000-0002-8480-3905 |
Appears in Collections: | (a) NT Health Research Collection |
Files in This Item:
There are no files associated with this item.
Items in ePublications are protected by copyright, with all rights reserved, unless otherwise indicated.